Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke

The invention relates to the use of non-neurotoxic plasminogen-activating factors, e.g. from Desmodus rotundus (DSPA) or genetically modified plasminogen-activating factors especially of human origin, for producing a therapeutic agent that is to be injected for the therapeutic treatment of stroke in...

Full description

Saved in:
Bibliographic Details
Main Authors WOLF-DIETER SCHLEUNING, WOLFGANG SOHNGEN, MARIOLA SOHNGEN, ROBERT MEDCALF
Format Patent
LanguageEnglish
Published 18.03.2010
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The invention relates to the use of non-neurotoxic plasminogen-activating factors, e.g. from Desmodus rotundus (DSPA) or genetically modified plasminogen-activating factors especially of human origin, for producing a therapeutic agent that is to be injected for the therapeutic treatment of stroke in humans.
Bibliography:Application Number: AU20100200718